Cynata Therapeutics Ltd has released a press release.
Offer Booklet and Entitlement & Acceptance Form
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Cynata Therapeutics Secures $15m Placement Led By $10m from Healthcare Investor BioScience Managers to Expand Development Pipeline
- Investor Presentation
- CYP Closes $15m Institutional Placement to Expand Pipeline
- Cynata Therapeutics: Phase 3 Osteoarthritis Clinical Trial Commences
- Potential Utility of Cymerus MSCs in Heart Attack Model
Later from Cynata Therapeutics
- Completion of Entitlement Offer and Shortfall Placement
- Cynata Receives $1.39m R&D Tax Incentive Refund
- Cynata Therapeutics Advances Planned Clinical Trial in Diabetic Foot Ulcers in MoU With TekCyte
- New Preclinical Study to Investigate the High Potency of Cymerus™ MSCs
- Cynata Expands trial in COVID-19 & Respiratory Failure
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics